Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · IEX Real-Time Price · USD
10.78
+0.31 (2.96%)
At close: Apr 26, 2024, 4:00 PM
10.90
+0.12 (1.11%)
After-hours: Apr 26, 2024, 6:09 PM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $381.62 million as of April 26, 2024. Its market cap has decreased by -53.13% in one year.
Market Cap
381.62M
Enterprise Value
214.68M
1-Year Change
-53.13%
Ranking
Category
Stock Price
$10.78
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $381.62M, a decrease of -21.97%. That is a compound annual growth rate of -7.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2024 | 375.80M | -2.77% |
| Apr 24, 2024 | 386.50M | -1.93% |
| Apr 23, 2024 | 394.10M | 1.39% |
| Apr 22, 2024 | 388.70M | -0.18% |
| Apr 19, 2024 | 389.40M | -2.77% |
| Apr 18, 2024 | 400.50M | -2.96% |
| Apr 17, 2024 | 412.70M | -3.78% |
| Apr 16, 2024 | 428.90M | -4.48% |
| Apr 15, 2024 | 449.00M | -3.61% |
| Apr 12, 2024 | 465.80M | -2.27% |
| Apr 11, 2024 | 476.60M | 4.08% |
| Apr 10, 2024 | 457.90M | -0.33% |
| Apr 9, 2024 | 459.40M | 2.32% |
| Apr 8, 2024 | 449.00M | -1.73% |
| Apr 5, 2024 | 456.90M | 0.99% |
| Apr 4, 2024 | 452.40M | -9.66% |
| Apr 3, 2024 | 500.80M | 9.01% |
| Apr 2, 2024 | 459.40M | -16.34% |
| Apr 1, 2024 | 549.10M | 2.35% |
| Mar 28, 2024 | 536.50M | -2.17% |
| Mar 27, 2024 | 548.40M | 2.74% |
| Mar 26, 2024 | 533.80M | -2.36% |
| Mar 25, 2024 | 546.70M | -3.58% |
| Mar 22, 2024 | 567.00M | -6.59% |
| Mar 21, 2024 | 607.00M | 7.74% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 388.55M |
| NeuroPace | 384.35M |
| PepGen | 383.17M |
| Alto Neuroscience | 381.75M |
| MultiPlan | 381.52M |
| Anika Therapeutics | 379.20M |
| iTeos Therapeutics | 378.86M |
| Pulse Biosciences | 378.85M |